Forum Topics CSX CSX CEO Interview

Pinned straw:

Added 3 months ago

I quite enjoyed this chat. And it's certainly peaked my interest with Cleanspace.

What I like:

  • Clear revenue momentum
  • Passed breakeven, with positive cash flow
  • High and growing gross margins
  • "Razor and blade" model, with 47% of sales for consumables.
  • Guidance for >20% revenue growth
  • Can double volumes without any material CAPEX
  • Founder still around
  • Forward P/S of 2.6x not excessive *if* sales momentum can be sustained and they can demonstrate good operating leverage


What to watch:

  • A tiny player in a competitive market
  • Short track record


Anyway, the recording is on the Meetings page and you can access the transcript here: CSX Transcript.pdf

Here's the chatGPT summary:

CleanSpace Technology (ASX: CSX) – CEO Gabrielle O’Carroll Interview Summary

Company Overview

  • Sydney-based designer and manufacturer of powered air-purifying respirators (PAPRs).
  • Products primarily target industrial sectors: mining, tunneling, welding, manufacturing, and fire services.
  • Recently launched the CleanSpace WORK respirator into the U.S. market.
  • Reported 26% revenue growth in FY25, with gross margins at ~75%, increased cash holdings, and positive free cash flow in 2H FY25.

Market Dynamics & Growth Drivers

  • Market growth: Global PAPR market projected to grow ~7% annually over the next five years.
  • Adoption tailwinds:
  • Rising awareness of respiratory safety (e.g., silicosis cases in tunneling projects).
  • Regulatory push from bodies like WorkSafe (AU), NIOSH (US), and global equivalents.
  • Legal and moral dimensions drive enterprises to invest in high-quality protection.
  • Geographic expansion: Increasing global reach, with varied adoption rates across countries.

Product Features & Differentiation

  • Price range: ~$900–$1,600 per unit, depending on the model.
  • AirSensit technology: Breath-responsive airflow adapts to user breathing rates, reducing battery size, weight, and user discomfort.
  • Bluetooth integration: Provides fit checks, usage tracking, and compliance reporting.
  • Data-driven insights:
  • Enables customers to monitor compliance, filter usage, procurement planning.
  • Differentiates CleanSpace from competitors; currently, competitors lack similar data capabilities.

Business Model

  • Razor-and-blade model:
  • Respirator units sold upfront; filters and masks drive recurring revenue (~47% of total revenue today).
  • Consumables have higher margins than units.
  • Distribution-focused sales:
  • Works through partners like Blackwoods in Australia.
  • Distributors hold inventory and provide after-sales support.
  • Aligns with market norms, where buyers expect to source PPE through established distributors.

Competitive Landscape

  • Competes against global giants: 3M, Honeywell, Dräger, Sundström, etc.
  • Key advantages over competitors:
  • Lightweight, head-mounted design with superior comfort and compatibility.
  • Bluetooth-enabled compliance reporting.
  • Faster customer service and shorter lead times (~10 days average).
  • Agility in innovation cycles compared to slower-moving multinationals.

Manufacturing & Capacity

  • In-house assembly in Sydney HQ; components sourced globally (mainly China & U.S.).
  • Scalable production capacity up to ~$50M in annual sales without major new investment.
  • Flexibility to increase output via additional shifts and workforce scaling.

Strategy & Innovation

  • Focused growth:
  • Doubling down on industrial markets, deliberately moving away from healthcare.
  • U.S. strategy: Rebuilt the sales team with industrial PPE expertise to penetrate the market methodically.
  • R&D investment:
  • Continuous innovation pipeline, with several projects under development.
  • Exploring lower-cost, mass-market models like the successful CleanSpace WORK, which already contributes 15% of global sales.
  • Bluetooth-driven data capabilities are expected to become a long-term differentiator.

Financial Position & Capital Allocation

  • Recently turned EBITDA and cash flow positive; goal is to sustain this through FY26 and beyond.
  • Capital priorities:
  • Invest in sales, marketing, and R&D to accelerate growth.
  • Expand support for distributors and end-users.
  • Explore capital management options (e.g., buybacks or dividends) once sustainable profitability is established.

Risks & Challenges

  • Competitive pressure from global incumbents with broader PPE portfolios.
  • Regulatory changes could impact product approvals and pricing.
  • Macro uncertainty (e.g., U.S. tariffs, geopolitical risks) could slow industrial investment and decision-making.
  • Managing shareholder expectations: balancing long-term innovation with short-term profitability.

Long-Term Vision (5-Year Outlook)

  • Doubling company size through:
  • New products from R&D pipeline.
  • Geographic expansion, including emerging markets (e.g., India).
  • Leveraging data and software integration.
  • Retain high-performance culture, strong customer service, and agility while scaling globally.

Key Takeaways

  • CleanSpace is transitioning from niche player to global contender in the PAPR market.
  • Differentiated by innovation, data capabilities, and customer focus.
  • Strong financial footing supports deliberate, focused expansion.
  • Long-term upside lies in scaling industrial markets, expanding consumable revenue, and embedding data-driven compliance into customer workflows.


Rapstar
Added 3 months ago

Just a reminder that Industrial sector sales growth has been up and to the right for 8 consecutive halves..........Albeit off a low base.


62b4e504318baf235bbda1f4c41981eb2b9e2a.png

15
mushroompanda
Added 3 months ago

Thanks for holding the interview with Gabrielle @Strawman. Once again a master class in the podcast style friendly deep dive that really brought out the best in the guest.

It occurred to me during the interview just how uniquely qualified Gabrielle is to assess Cleanspace’s strengths and weaknesses against the big multinational conglomerates - having worked in senior positions at 3M including a 3 year stint in the PPE division.

So when she says Cleanspace’s competitive advantage is around innovation, customer experience (fast shipping, questions answered within 24 hours), and agility (making quick decisions that resonate with customers) - I believe her, because she would know.

Cleanspace feels like a very interesting company at an inflection point, finally hitting its straps.

26
Stumpy
Added 3 months ago

Thanks for organising the call Andrew, I attended and found it informative.

A couple of takeaways for me:

  • While not for all investors, I appreciated her general vibe of underpromising and keeping cards close to her chest especially regarding R&D and future product releases. You alluded to this when you mentioned CEO’s that jump on these calls and generate excitement and expectations that they then fail to deliver on. I much rather prefer management that underpromise and overdeliver ala Supply Network Limited, Wisetech etc.
  • Her emphasis on the pivot away from healthcare to a trade/industry focus gave me confidence in management’s clarity for the direction of the business. While they’ve been in business for years now, I think the pivot makes past financials and reports a bit less useful as a guide for future performance. Makes it more of an exercise in predicting their share of a different TAM.
  • I want to do more research on competitor offerings in the PAPR space. A quick 5 min check appeared to back up her comments about the Cleanspace products being the most portable PAPR solution, but I’m going to dig a bit deeper into portability vs efficacy of the different products out there. When you’re a small player in a big market, you need to have a bloody good moat to stay afloat.

15